Cost Effectiveness of Zanamivir for the Treatment of Influenza in a High Risk Population in Australia

By Mauskopf J.A.  

PharmacoEconomics, Vol. 17, Iss. 6, 2000-06 ,pp. : 611-620

Adis International

Access to resources Recommend Favorite

Clinical Efficacy of Inhaled Zanamivir for the Treatment of Patients with Influenza B Virus Infection: A Pooled Analysis of Randomised, Placebo-Controlled Studies

By Osterhaus A.D.M.E.  

Clinical Drug Investigation, Vol. 20, Iss. 4, 2000-10 ,pp. : 223-228

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of the Sirolimus-Eluting Stent in High-Risk Patients in Canada: An Analysis from the C-SIRIUS Trial

By Rinfret Stéphane  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 159-168

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Oseltamivir Treatment for Patients with Influenza-Like Illness Who Are at Increased Risk for Serious Complications of Influenza: Illustration for The Netherlands

By Postma Maarten J.  

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 497-509

Adis International

Access to resources Recommend Favorite

Contemporary cost-effectiveness analysis comparing sequential bacillus Calmette-Guerin and electromotive mitomycin versus bacillus Calmette-Guerin alone for patients with high-risk non–muscle-invasive bladder cancer

By Bachir Bassel G.   Dragomir Alice   Aprikian Armen G.   Tanguay Simon   Fairey Adrian   Kulkarni Girish S.   Breau Rodney H.   Black Peter C.   Kassouf Wassim  

Cancer, Vol. 120, Iss. 16, 2014-08 ,pp. : 2424-2431

Blackwell Publishing

Access to resources Recommend Favorite